Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1
Natalia Stella-Ascariz(Hospital La Paz Institute for Health Research), Rosa de Miguel Buckley, Berta Rodés(Madrid Health Service), Clotilde Allavena(Centre Hospitalier Universitaire de Nantes), Rocío Montejano, Belén Alejos, José Ramón Arribas(Hospital Universitario La Paz), Magnus Gisslén(Public Health Agency of Sweden), Javier Rodríguez-Centeno(Hospital La Paz Institute for Health Research), Andrés Esteban-Cantos(Hospital La Paz Institute for Health Research), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), François Raffi(Centre Hospitalier Universitaire de Nantes), Christine Schwimmer(Université de Bordeaux), José Ignacio Bernardino(Hospital Universitario La Paz), Cédrick Wallet(Université de Bordeaux)
Cited by 33
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342